在心房的微RNAs在结构重塑中准基因
Nicoline W E van den Berg1, Makiri Kawasaki2, Fransisca A Nariswari2
1Amsterdam UMC, University of Amsterdam, Heart Center; Department of Clinical and Experimental Cardiology and Cardiothoracic Surgery, Amsterdam Cardiovascular Sciences, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. n.w.vandenberg@amsterdamumc.nl.
Cell and tissue research
|October 13, 2023
概括
这项研究揭示了微RNA (miRNA) 如何影响心房动 (AF) 的基因表达. 特定的miRNA被确定为AF患者抗纤维治疗的潜在治疗标.
科学领域:
- 心血管生物学 心血管生物学
- 分子遗传学 分子遗传学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 心房动 (AF) 涉及复杂的分子变化,包括改变的基因表达.
- 微RNAs (miRNAs) 是基因表达的关键调节者,与心血管疾病有关.
研究的目的:
- 研究miRNAs在调节心房动中mRNA表达模式中的作用.
- 为了确定新型抗纤维性治疗AF的潜在miRNA点.
主要方法:
- 结合miRNA和mRNA测序的心房组织从没有AF的患者,有偏激性AF,和持久的AF.
- 生物信息分析以将miRNA表达与目标mRNA水平相关联.
- 在体外实验验验证特定miRNAs (miR-135b-5p,miR-138-5p) 对目标基因的功能影响.
主要成果:
- 在AF中确定了特定的下调 (例如,miR-135b-5p,miR-138-5p) 和上调 (例如,miR-144-3p,miR-206) 的miRNA.
- 观察到miRNA表达及其预测的基因之间的负相关性.
- 证明了下调的miRNA与上调的途径有关,例如上皮质-介质细胞过渡和糖氨基酸糖生物合成.
- 在体外验证了miR-135b-5p和miR-138-5p在多个向基因上的调控作用.
结论:
- MiRNAs在塑造心房动的mRNA特征方面发挥着重要作用.
- 已识别的miRNAs,特别是调控下来的miRNAs,代表了作为AF治疗点的进一步研究的有希望的候选人.
- 这些发现提供了关于AF病变的机制性见解,以及开发抗纤维性药物的潜在途径.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
441
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
441
01:28Mechanism of Cardiac Arrhythmias
929
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
929